Skip to main content

Day: July 30, 2020

Lifequest World Corp Appoints TraDigital IR as its Investor Relations Advisor

RIDGEFIELD PARK, NEW JERSEY, July 30, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — LIFEQUEST WORLD CORP (LQWC) today announced the appointment of TraDigital IR, a leading financial and digital media communications firm, as its investor relations advisor.Max Khan, CEO of Lifequest, commented, “We are pleased to appoint TraDigital as our investor relations advisor. TraDigital’s industry expertise and capital market knowledge will assist Lifequest in its efforts to strengthen our communication with investors and improve market awareness of our company. We look forward to working closely with TraDigital to convey our business story, growth strategy, competitive advantages, and value proposition to the investment community.”  “Our team is excited about having been appointed IR advisor to Lifequest,” said MJ Clyburn, founder...

Continue reading

Nokia completes its first 5G standalone call on live network with China Unicom

First call achieved within 25 days of Nokia software deployment, surpassing the performance of other solutions in the marketCall underscores the interoperability of Nokia Software products, irrespective of hardware environment30 July 2020 Espoo, Finland – Nokia today announced that it has successfully completed its first 5G standalone (SA) call on a live network with China Unicom, and is expected to achieve full deployment of numerous software solutions with the operator several weeks ahead of schedule.The data and voice calls, which marked firsts for Nokia on a 5G SA network, were completed earlier than planned in part due to Nokia’s experience-driven, customer-focused approach. By bypassing non-standalone (NSA) 5G core deployments entirely, Nokia was able to deliver 5G SA core for China Unicom and enable crucial network functions, such...

Continue reading

Lifted Made Launches Flavored Nano CBD Water Enhancer Packets Under its Urb Finest Flowers Brand

ZION, Il, July 30, 2020 (GLOBE NEWSWIRE) — Lifted Made, a wholly owned subsidiary of publicly traded Acquired Sales Corp. (OTC Pink: AQSP), is excited to announce its launch of flavored nano CBD water enhancer packets under Lifted Made’s flagship brand Urb Finest Flowers (Instagram @LiftedMade).Urb’s nano CBD water enhancer packets are water soluble and are available in four delicious flavors: mango, blue razz, watermelon and lemon. Each packet  contains approximately 10 mg. of CBD, and less than 0.3% delta-9-THC. The packets are for sale in a box of 24 for $71.76 ($2.99 each). The packets are available for purchase online at www.LiftedMade.com and will be distributed to brick and mortar stores throughout the USA.Nicholas S. Warrender, CEO of Lifted Made, and Vice Chairman and COO of Acquired Sales Corp., commented: “Urb’s nano...

Continue reading

Vivos Inc Reports Additional IsoPet Therapies

Richland WA, July 30, 2020 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL), Interest in IsoPet therapy is increasing. Yesterday Vivos Inc treated “Mister Motto” a cat that the pet parents flew to the state of Washington from New York City. As interest and awareness continues to increase, pet parents are making it a priority to obtain therapy even with the challenges presented by the Corona Virus. The owner of our previous patient drove twelve hours from California and we are pleased to report that the large spindle cell tumor decreased 30% in size in five weeks.Dr. Mike Korenko stated “Over the last twelve months we have had expressions of Interest for IsoPet therapy for patients in thirteen states, Vancouver BC and Montreal Canada. Over time word is spreading on the IsoPet therapy. We will continue to publish our results and will present...

Continue reading

Codexis to Hold Second Quarter 2020 Conference Call on August 6

REDWOOD CITY, Calif., July 30, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report second quarter 2020 financial results after market close on Thursday, August 6, 2020. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update.We encourage participants to pre-register for the conference call using the following link: http://dpregister.com/10146500. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.Those without internet access or unable to pre-register may dial in...

Continue reading

Imara Announces IMR-687 Granted Fast Track Designation and Rare Pediatric Disease Designation for Treatment of Beta-Thalassemia

BOSTON, July 30, 2020 (GLOBE NEWSWIRE) — IMARA Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation and Rare Pediatric Disease designation for its lead clinical asset, IMR-687, for the treatment of beta-thalassemia. The FDA previously granted Orphan Drug designation for IMR-687 for the treatment of patients with beta-thalassemia and Orphan Drug, Fast Track and Rare Pediatric Disease designations for the treatment of patients with sickle cell disease.“We are pleased to receive from the FDA both Fast Track designation and Rare Pediatric Disease designation for IMR-687. Fast Track designation...

Continue reading

Unitil Reports Second Quarter Earnings

HAMPTON, N.H., July 30, 2020 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (www.unitil.com) today announced Net Income of $3.1 million, or $0.21 in Earnings Per Share (EPS), for the second quarter of 2020, a decrease of $0.9 million in Net Income, or $0.06 per share, compared to the second quarter of 2019, driven by lower gas sales margins and higher operating expenses. The second quarter of 2019 included $0.6 million in property tax abatements resulting from the Company’s litigation of property valuation assessments which contributed $0.03 per share to results in 2019.For the six months ended June 30, 2020, the Company reported Net Income of $18.3 million, or $1.23 per share, a decrease of $12.2 million, or $0.82 per share, compared to the same six month period in 2019. In the first quarter of 2019 the Company recognized a...

Continue reading

Stantec awarded The Water Research Foundation study to define digital water transformation and intelligent water utility framework of the future

EDMONTON, Alberta and NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) — The Water Research Foundation (WRF) awarded Stantec the lead in a global collaboration of utility and technology experts to define the framework for the digital transformation of the water industry. The project, titled Definition of Smart Utility – How to be a Digital Utility and the Framework for an Intelligent Water System (WRF 5039), is funded by WRF with monetary support from the Great Lakes Water Authority, as well as the in-kind support of research participants. The intended outcome of this collaboration is to assist utility leaders to make better, data-driven decisions supported by an Intelligent Water Systems (IWS) framework.Video: Stantec leads study to define digital framework for smart utility of the future“Although various research organizations, utilities,...

Continue reading

Obalon Announces Second Quarter 2020 Financial Results

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for the second quarter ended June 30, 2020.Financial results for the second quarter of 2020Revenue for the second quarter of 2020 was $0.7 million, compared to $0.4 million for the second quarter of 2019, primarily due to reversals of revenue reserves as a result of suspending business operations at the company-branded retail treatment centers. Net loss for the second quarter of 2020 was $4.2 million, compared to $6.8 million for the second quarter of 2019. Net loss per share for the second quarter of 2020 was $0.54, compared to $2.52 for the...

Continue reading

Brunswick Releases Second Quarter 2020 Earnings

METTAWA, Ill., July 30, 2020 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) today has released its second quarter 2020 financial results. A complete and full-text financial results press release is available on the Company’s website at www.brunswick.com/investors.  The results will also be available on the SEC’s website with the Form 8-K filing of the release at https://goo.gl/wJQN1.The Company will hold a conference call today at 10 a.m. CDT hosted by David M. Foulkes, chief executive officer, Ryan M. Gwillim, senior vice president – chief financial officer and Brent Dahl, vice president.The call will be broadcast over the Internet at www.brunswick.com/investors. To listen to the call, go to the website at least 15 minutes before the call to register, download and install any needed audio software.See Brunswick’s website for...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.